Survey: Healthcare Providers Recognizing Benefits of IT to Meet Federal Requirements

Dec. 17, 2015
Although the healthcare industry has often lagged behind other sectors in its use of IT, the majority of hospitals are now leveraging technology to meet the requirements of federal initiatives such as meaningful use and accountable care, according to a recent survey from IDC Health Insights.

Although the healthcare industry has often lagged behind other sectors in its use of IT, the majority of hospitals are now leveraging technology to meet the requirements of federal initiatives such as meaningful use and accountable care, according to a recent survey from IDC Health Insights.

The new IDC InfoBrief, commissioned by Tokyo-based imaging and print company Ricoh Americas Corporation, gained insight from approximately 100 health IT executives and 500 hospital employees. With nearly 83 percent of hospitals reporting opportunities to integrate workflows across departments, the healthcare industry is poised to see significant gains from information mobility related to meaningful use and accountable care, the report found.

Healthcare organizations are seeking to improve care coordination and clinical processes across departments to achieve long-term goals, according to the survey. In fact, 85 percent of hospitals noted their internal departments could optimize their document workflows. Importantly, they also reported document image data is as critical as paper documents to their business needs, as doctors and nurses need access to electronic versions of documents for proper patient treatment.

Hospitals have identified key challenges, including workflow inefficiencies, departmental silos and lack of access to mobile and cloud applications that could impede their information mobility goals. The survey found that while 69 percent of hospital employees are satisfied with their ability to print, scan and access applications from a mobile device, improvements to the way healthcare practitioners capture, transform and manage patient data can be made, particularly related to helping them attain meaningful use goals for electronic health record (EHR) use. Recognizing the benefits of mobile document capture, hospitals are in the early stages of mobile technology deployments that will expand immediate access to critical patient data for employees and patients.

What’s more, hospitals are reporting the strongest improvements from information mobility technology in work quality (28 percent), information flow within departments (27 percent) and time employees dedicate to their patients (27 percent), contributing to enhanced patient care and satisfaction. As organizations continue to see efficiencies and process enhancements in these areas, they will supplement ongoing gains in meaningful use and accountable care. Ultimately these benefits to patient care can translate to business benefits for hospitals, as patient perspectives of care influence hospital reimbursement rates, the report concluded.

“The healthcare industry has historically invested less in technology than other industries, but government regulations incentivizing technology upgrades have spurred the next wave in information mobility for healthcare,” Lynne Dunbrak, research vice president, connected health it strategies, IDC Health Insights, said in a statement. “The need to access the right data at a moment’s notice is even more critical in the healthcare industry when patient care is at stake. As hospitals realize the benefits to population health, meaningful use gains and accountable care, they are steadily making investments to improve their workflows and IT infrastructure for greater access to information.”

Sponsored Recommendations

Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

Beyond the Silos: Transforming Coordinated Care Across Healthcare Systems

Coordinated healthcare is vital to delivering a high-quality patient experience, yet it has been difficult to systematize across all healthcare settings. Although it has largely...

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1